Viewing Study NCT04161092


Ignite Creation Date: 2025-12-24 @ 3:54 PM
Ignite Modification Date: 2025-12-24 @ 3:54 PM
Study NCT ID: NCT04161092
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-10-28
First Post: 2019-10-31
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: The Swedish Study of Liver Transplantation for Non-resectable Colorectal Cancer Metastases
Sponsor: Vastra Gotaland Region
Organization:

Study Overview

Official Title: A Randomized Controlled, Open-label, Multicentre Study Evaluating if Liver Transplantation With Liver Grafts From Extended Criteria Donors Not Utilised for Approved Indications Increases Overall Survival in Patients With Non-resectable Isolated Liver Metastases From Colorectal Metastases, in Comparison With Best Alternative Care
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SOULMATE
Brief Summary: To evaluate if the addition of liver transplantation primarily utilizing liver grafts from extended criteria donors not utilized for approved indications to conventional treatment of non-resectable/ non-abatable colorectal liver metastases (CLM) increases overall survival compared to best alternative care.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: